journal article·2025-04Open access

PVP formulations of bis-cyclometalated iridium(III) complexes bearing β-modified porphyrin ligands: Characterization and photodynamic action on bladder cancer cells

Nuno M.M. Moura, Melani J.A. Reis, Carlos Lodeiro, M. Graça P.M. S. Neves, José A.S. Cavaleiro, Carlos F. Ribeiro, Rosa Fernandes, Ana T.P.C. Gomes

Dyes and Pigments· Volume 235

Abstract

Cancer stands as the second leading global cause of death, following heart disease. Considering the severe side effects revealed by some chemotherapeutics for tumor treatment and anticancer therapies, the scientific community is actively exploring more effective alternatives. Photodynamic Therapy (PDT) mediated by porphyrin-based photosensitizers (PS) has emerged as an attractive alternative to more conventional therapies. In this study, we incorporated bis-cyclometalated iridium(III) complexes featuring porphyrin-arylbipyridine ligands into poly(vinylpyrrolidone) (PVP) micelle. This integration resulted in photostable PVP-PS formulations with a remarkable capability to generate singlet oxygen. These formulations were also efficiently internalized by HT-1379 cells and due to these features, their photodynamic action against human bladder cancer cells (HT-1376 cell line) was assessed. All the formulations demonstrated high photodynamic activity, with PVP-2 and PVP-3 proving to be the most promising PS, as evidenced by their lower IC50 PDT values. It was also demonstrated that all PVP-based formulations provide a safe and effective approach for photodynamic therapy (PDT) in bladder cancer, as no cytotoxic effects were observed in Vero cells. • Properties of porphyrin-Ir(III) complexes were not altered following inclusion into PVP micelles • PVP formulations have a remarkable capability to generate single oxygen and good photostability • PVP formulations were efficiently internalized and did not cause dark toxicity • All PVP-PS formulations prepared showed high photodynamic activity against HT-1376 cancer cells • This approach allows for the use of non-water-soluble porphyrins-Ir(III) as PS in PDT
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Porphyrin and Phthalocyanine Chemistry · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. Recent advances on organelle specific Ru(II)/Ir(III)/Re(I) based complexes for photodynamic therapy10.1016/j.ccr.2022.214860 ↗
2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
3. Optical – magnetic probe for evaluating cancer therapy10.1016/j.ccr.2021.213978 ↗
4. The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 202210.1016/j.ejmech.2022.114680 ↗
5. Platinum-based combination therapy: molecular rationale, current clinical uses, and future perspectives10.1021/acs.jmedchem.0c00950 ↗
6. Platinum-based anticancer drugs encapsulated liposome and polymeric micelle formulation in clinical trials
7. Anticancer platinum(II) complexes bearing N-heterocycle rings10.1016/j.bmcl.2019.03.045 ↗
8. Mitochondrial involvement in cisplatin resistance10.3390/ijms20143384 ↗
9. Cisplatin-membrane interactions and their influence on platinum complexes activity and toxicity10.3389/fphys.2018.01898 ↗
10. Unraveling the photodynamic activity of cationic benzoporphyrin-based photosensitizers against bladder cancer cells10.3390/molecules26175312 ↗
11. Post-complexation functionalization of cyclometalated iridium(III) complexes and applications to biomedical and material sciences
12. Recent development and application of cyclometalated iridium(III) complexes as chemical and biological probes10.1039/D1DT00592H ↗
13. Supramolecular iridium(III) assemblies10.1016/j.ccr.2018.03.016 ↗
14. Excited-state dynamics of luminescent transition metal complexes with metallophilic and donor–acceptor interactions10.1016/j.ccr.2022.214610 ↗
15. Near-infrared emitting iridium complexes: molecular design, photophysical properties, and related applications
16. Bioinspired molecular clusters for water oxidation10.1016/j.ccr.2021.214164 ↗
17. Red to near-infrared phosphorescent Ir(III) complexes with electron-rich chelating ligands10.1039/D0CC08067E ↗
18. Catalytic enantioselective functionalizations of C–H bonds by chiral iridium complexes10.1021/acs.chemrev.0c00559 ↗
19. Trip in the nonlinear optical properties of iridium complexes10.1016/j.ccr.2020.213293 ↗
20. A brief history of OLEDs—emitter development and industry milestones10.1002/adma.202005630 ↗
21. Luminescent metal complexes as emerging tools for lipid imaging
22. Phosphorescent Ir(III) complexes for biolabeling and biosensing
23. Recent advances in catalytic anticancer drugs: mechanistic investigations and future prospects10.1016/j.ica.2021.120754 ↗
24. Advances in novel iridium (III) based complexes for anticancer applications: a review10.1016/j.ica.2020.119925 ↗
25. Identification of an iridium(III) complex with anti-bacterial and anti-cancer activity
26. Phototherapeutic anticancer strategies with first-row transition metal complexes: a critical review10.1039/D1CS00609F ↗
27. Transition metal complexes as photosensitizers for integrated cancer theranostic applications10.1016/j.ccr.2020.213355 ↗
28. Photodynamic therapy for hypoxic tumors: advances and perspectives10.1016/j.ccr.2021.213888 ↗
29. Type I photosensitizers revitalizing photodynamic oncotherapy
30. Reactive oxygen species (ROS)-Based nanomedicine10.1021/acs.chemrev.8b00626 ↗
31. Cancer, photodynamic therapy and porphyrin-type derivatives10.1590/0001-3765201820170811 ↗
32. Engineering of relevant photodynamic processes through structural modifications of metallotetrapyrrolic photosensitizers10.1016/j.ccr.2016.06.007 ↗
33. Supramolecular agents for combination of photodynamic therapy and other treatments10.1039/D1SC01125A ↗
34. Porphyrins and related macrocycles: combining photosensitization with radio- or optical-imaging for next generation theranostic agents10.1016/j.pdpdt.2018.06.023 ↗
35. A promising anticancer drug: a photosensitizer based on the porphyrin skeleton10.1039/C9MD00558G ↗
36. Revisiting current photoactive materials for antimicrobial photodynamic therapy10.3390/molecules23102424 ↗
37. An insight into the potentiation effect of potassium iodide on aPDT efficacy10.3389/fmicb.2018.02665 ↗
38. Kadish · 2010
39. Design and applications of molecular probes containing porphyrin derivatives10.1016/j.ccr.2017.06.008 ↗
40. Porphyrinoids for chemical sensor applications10.1021/acs.chemrev.6b00361 ↗
41. Synthesis, spectroscopy studies, and theoretical calculations of new fluorescent probes based on pyrazole containing porphyrins for Zn(II), Cd(II), and Hg(II) optical detection10.1021/ic500634y ↗
42. Visible-light responsive organic nano-heterostructured photocatalysts for environmental remediation and H-2 generation10.1016/j.jmst.2019.09.003 ↗
43. New hybrid adsorbent based on porphyrin functionalized silica for heavy metals removal: synthesis, characterization, isotherms, kinetics and thermodynamics studies10.1016/j.jhazmat.2017.10.058 ↗
44. Supramolecular hybrid material based on engineering porphyrin hosts for an efficient elimination of lead(II) from aquatic medium10.3390/molecules24040669 ↗
45. Photodegradation of metoprolol using a porphyrin as photosensitizer under homogeneous and heterogeneous conditions10.1016/j.jhazmat.2018.11.055 ↗
46. Oxygen reduction by homogeneous molecular catalysts and electrocatalysts10.1021/acs.chemrev.7b00542 ↗
47. Novel hybrids of graphitic carbon nitride sensitized with free-base meso-tetrakis(carboxyphenyl) porphyrins for efficient visible light photocatalytic hydrogen production10.1016/j.apcatb.2017.08.079 ↗
48. Energy-related small molecule activation reactions: oxygen reduction and hydrogen and oxygen evolution reactions catalyzed by porphyrin- and corrole-based systems10.1021/acs.chemrev.6b00299 ↗
49. Current issues in molecular catalysis illustrated by iron porphyrins as catalysts of the CO2-to-CO electrochemical conversion10.1021/acs.accounts.5b00262 ↗
50. Visible-light-Driven production of solar fuels catalyzed by nanosized porphyrin-based metal–organic frameworks and covalent–organic frameworks: a review10.1021/acsanm.2c00831 ↗
51. β-Pyrrole functionalized porphyrins: synthesis, electronic properties, and applications in sensing and DSSC10.1016/j.ccr.2021.214312 ↗
52. Porphyrin and single atom featured reticular materials: recent advances and future perspective of solar-driven CO2 reduction10.1039/D1GC02439F ↗
53. Bioinspired applications of porphyrin derivatives10.1021/acs.accounts.1c00114 ↗
54. beta-Substituted Zn-II porphyrins as dyes for DSSC: a possible approach to photovoltaic windows10.1016/j.ccr.2017.12.012 ↗
55. New insight into the application of fluorescence platforms in tumor diagnosis: from chemical basis to clinical application
56. Lanthanide–tetrapyrrole complexes: synthesis, redox chemistry, photophysical properties, and photonic applications10.1039/C9CS00828D ↗
57. Comparison of the photodynamic action of porphyrin, chlorin, and isobacteriochlorin derivatives toward a melanotic cell line10.1021/acsabm.1c00218 ↗
58. Emerging perspectives on applications of porphyrinoids for photodynamic therapy and photoinactivation of microorganisms10.6060/mhc181220t ↗
59. Transition metal complexes as photosensitisers in one- and two-photon photodynamic therapy10.1016/j.ccr.2018.03.020 ↗
60. Synthesis of chlorins and bacteriochlorins from cycloaddition reactions with porphyrins10.24820/ark.5550190.p011.696 ↗
61. Tetracationic porphyrin derivatives against human breast cancer10.1016/j.jphotobiol.2021.112258 ↗
62. New nitroindazole-porphyrin conjugates: synthesis, characterization and antibacterial properties10.1016/j.bioorg.2020.103994 ↗
63. Antimicrobial photodynamic inactivation: a bright new technique to kill resistant microbes10.1016/j.mib.2016.06.008 ↗
64. Fathi · 2020 · vol. 15 · 2493
65. Graphene oxide and graphene quantum dots as delivery systems of cationic porphyrins: photo-antiproliferative activity evaluation towards t24 human bladder cancer cells10.3390/pharmaceutics13091512 ↗
66. Merging pyridine(s) with porphyrins and analogues: an overview of synthetic approaches10.1016/j.dyepig.2021.109298 ↗
67. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy10.1021/acs.chemrev.1c00381 ↗
68. Rational design of iridium–porphyrin conjugates for novel synergistic photodynamic and photothermal therapy anticancer agents10.1039/D1SC00126D ↗
69. Metallomesogens with luminescent behaviour: palladium complexes derived from alkylamide tetraarylporphyrins10.1002/cplu.201500557 ↗
70. Ruthenium and iridium complexes bearing porphyrin moieties: PDT efficacy against resistant melanoma cells10.1016/j.dyepig.2022.110501 ↗
71. Spectroscopic study of NH-tautomerism in novel cycloketo-tetraphenylporphyrins10.1063/1.3098316 ↗
72. New bis-cyclometalated iridium(III) complexes with β-substituted porphyrin-arylbipyridine as the ancillary ligand: electrochemical and photophysical insights10.3390/ijms23147606 ↗
73. Synthesis and photophysical properties of sulfonamidophenyl porphyrins as models for activatable photosensitizers10.1021/jo900832y ↗
74. ISO10993-5
75. A simple and low-cost resazurin assay for vitality assessment across species10.1016/j.jbiotec.2021.04.010 ↗
76. The n-octanol:water partition coefficients (miLog P) were evaluated using the MolinspirationWebME Editor 3.81, http://www.molinspiration.com (accessed august 2021). n.d.
77. Pharmaceutical assessment of polyvinylpyrrolidone (PVP): as excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition
78. Multifunctional role of polyvinylpyrrolidone in pharmaceutical formulations10.1208/s12249-020-01909-4 ↗
79. The use of poly(N-vinyl pyrrolidone) in the delivery of drugs: a review10.3390/polym12051114 ↗
80. Toward understanding the high PDT efficacy of chlorin e6-polyvinylpyrrolidone formulations: Photophysical and molecular aspects of photosensitizer-polymer interaction in vitro10.1016/j.jphotobiol.2008.06.004 ↗
81. Kashef · 2017 · vol. 6
82. Local delivery of antimicrobial agents for the treatment of periodontal diseases10.1016/S0939-6411(00)00086-2 ↗
83. Efficient catalytic oxidation of 3-arylthio- and 3-Cyclohexylthio-lapachone derivatives to new sulfonyl derivatives and evaluation of their antibacterial activities10.3390/molecules22020302 ↗
84. Synthesis, characterization and photodynamic activity against bladder cancer cells of novel triazole-porphyrin derivatives10.3390/molecules25071607 ↗
85. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems10.3390/pharmaceutics10020057 ↗
86. The warburg effect: how does it benefit cancer cells?10.1016/j.tibs.2015.12.001 ↗
87. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles10.1016/j.jconrel.2013.09.013 ↗
88. Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs10.1016/j.ijpharm.2012.08.042 ↗
89. Theoretical study of the Q and B bands of free-base, magnesium, and zinc porphyrins, and their derivatives10.1021/jp984807d ↗
90. Excited-state absorption investigation of a cationic porphyrin derivative10.1016/j.jphotochem.2010.06.007 ↗
91. Ultrafast dynamics of porphyrins in the condensed phase: I. Free base tetraphenylporphyrin10.1021/jp020398g ↗
92. Luminescence of some metalloporphins including the complexes of the IIIb metal group10.1063/1.448410 ↗
93. Porphyrins. XIII: fluorescence spectra and quantum yields10.1016/0022-2852(69)90335-X ↗
94. Montalti · 2006
95. Berlman · 1971
96. Synthesis, properties and in vitro photodynamic activity of water-soluble azaphthalocyanines and azanaphthalocyanines10.1111/j.1751-1097.2009.00647.x ↗
97. Synthesis, properties and photodynamic inactivation of Escherichia coli by novel cationic fullerene C60 derivatives10.1016/j.ejmech.2007.06.014 ↗
98. Singlet oxygen quantum yields of different photosensitizers in polar solvents and micellar solutions10.1002/(SICI)1099-1409(199803/04)2:2<145::AID-JPP60>3.0.CO;2-2 ↗
99. Novel pyrazoline and pyrazole porphyrin derivatives: synthesis and photophysical properties10.1016/j.tet.2012.07.072 ↗
100. Photophysical and photochemical properties of potential porphyrin and chlorin photosensitizers for PDT10.1016/1011-1344(95)07241-1 ↗